Chapter 7 Key Concepts Flashcards
Factors that distinguish benign from malignant tumors (4)
Degree of differentiation
Rate of Growth
Local invasiveness
Distant Spread
Appearance of benign tumors
resemble tissue of origin and are well differentiated
Appearance of malignant tumors
less well differentiated or completely undifferentiated (anaplastic)
Functionality of benign tumors
retain functions of cells of origin
Functionality of malignant tumors
acquire unexpected functions due to derangements in differentiation
Growth of benign tumors
slow growing
Growth of malignant tumors
grow faster
Structure of benign tumors
circumscribed and have a capsule
Structure of malignant tumors
poorly circumscribed and invade surrounding normal tissues
Localization of benign tumors
remain localized at the site of origin
Localization of malignant tumors
metastasize to distant sites
Factors that influence epidemiology of cancer (4)
geography, age, race, genetic background
Age when cancer is most common
older than 60 years of age but can occur in adults, children, and infants
Geographic influence on cancers
mainly stem from different environmental factors
Important environmental factors in carcinogens (7)
infectious agents smoking alcochol diet obesity reproductive history exposure to environmental factors
What can cause increased risk of cancer due to reparative proliferations? (4)
chronic inflammation
tissue injury
hyperplasia
immunodeficiency
Environmental and genetic influence on cancer
important determinants of cancer risk
Proto-oncogenes
normal cellular genes whose products promote cell proliferation
Oncogenes
Mutated or overexpressed versions of proto-oncogenes that function autonomously
Lost dependence on normal growth promoting signals
Oncoprotein
protein encoded by an oncogene that drives increased cell proliferation through one of several mechanisms
Expression of growth factors and growth factor receptors
set up autocrine signaling loop
What constitutive signaling do mutations in growth factor receptors, non-receptor tyrosine kinases, or downstream signaling molecules lead to? (6)
Activation of EGF receptor tyrosine kinase
Activation of HER2 receptor tyrosine kinase
Activation of JAK2 tyrosine kinase
Activation of ABL nonreceptor tyrosine kinase
Activation of RAS by point muation
Activation of PI3K and BRAF serine/threonine kinases
EGF receptor tyrosine kinase
lung cancer by point mutations
HER2 receptor tyrosine kinase
breast cancer by gene amplification
JAK2 tyrosine kinase
myeloproliferative disorders by point mutations
ABL nonreceptor tyrosine kinase
chronic myelogenous leukemia, acute lymphoblastic leukemia by chromosomal translocation and creation of BCR-ABL fusion gene
RAS
many cancer by point mutation